Brief: Fortrea & Emery Pharma Announce Strategic Collaboration To Deliver FDA Compliant Drug
24/06/2025 12:04
June 24 (Reuters) - Fortrea Holdings Inc FTRE.O: FORTREA & EMERY PHARMA ANNOUNCE STRATEGIC COLLABORATION TO DELIVER FDA COMPLIANT DRUG-DRUG-INTERACTION STUDIES USING RIFAMPIN Source text: ID:nGNX1kMJxN Further company coverage: FTRE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortrea Holdings
See all newsFortrea Q3 revenue beats expectations on bookings momentum, guidance raised
Brief: Fortrea And Omico Collaboration To Advance Biomarker-Led Oncology Drug Development
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler
Brief: Fortrea Completes Acquisition Of The Early Phase Services Division From Worldwide Clinical Trials
US RESEARCH ROUNDUP-Acuity, Dell Technologies, Nike